0000899243-16-021000.txt : 20160526 0000899243-16-021000.hdr.sgml : 20160526 20160526122941 ACCESSION NUMBER: 0000899243-16-021000 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160525 FILED AS OF DATE: 20160526 DATE AS OF CHANGE: 20160526 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001358762 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113651945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2801 GATEWAY DRIVE SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 BUSINESS PHONE: 972-865-2206 MAIL ADDRESS: STREET 1: 2801 GATEWAY DRIVE SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Huff James Warren CENTRAL INDEX KEY: 0001662411 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37785 FILM NUMBER: 161677106 MAIL ADDRESS: STREET 1: C/O REATA PHARMACEUTICALS, INC. STREET 2: 2801 GATEWAY DR. SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-05-25 0 0001358762 REATA PHARMACEUTICALS INC RETA 0001662411 Huff James Warren 2801 GATEWAY DRIVE, SUITE 150 IRVING TX 75063 1 1 0 0 See Remarks Employee Stock Option (right to buy) 11.00 2016-05-25 4 A 0 113636 0.00 A 2026-05-25 Class B common stock 113636 113636 D The options vest in sixteen equal quarterly installments beginning on August 25, 2016, subject to continued service through each vesting date. The Class B common stock is convertible into Class A common stock on a one-for-one basis (a) at the holder's election at any time after the date that is six months following the date of the closing of the initial public offering of the company's Class A common stock, (b) at the holder's election prior to that time subject to certain conditions, or (c) at the option of the company's board of directors, in its sole discretion, at any time or multiple times from time to time on or before the closing of the initial public offering. The conversion right of the Class B common stock has no expiration date. Chief Executive Officer, President, and Chairman of the Board of Directors /s/ Michael D. Wortley, attorney-in-fact 2016-05-25